Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 4:30 PM View:  | Benkowitz Michael President and COO | United Therapeutics Corp. (UTHR) | 18-Nov-24 | Option Exercise | 10,000 | $104.33 | $1,043,330.00 | 100% 0 to 10.0K | |
| 19-Nov-24 4:30 PM View: | Benkowitz Michael President and COO | United Therapeutics Corp. (UTHR) | 18-Nov-24 | Planned Option Sale | 10,000 | $359.21 | $3,592,070.00 | (100%) 10.0K to 0 | |
| 15-Oct-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 14-Oct-24 | Planned Option Sale | 7,792 | $355.88 | $2,773,020.00 | (55%) 14.22K to 6.43K | |
| 15-Oct-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 14-Oct-24 | Option Exercise | 8,334 | $143.46 | $1,195,620.00 | 142% 5.88K to 14.22K | |
| 08-Oct-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 07-Oct-24 | Option Exercise | 8,334 | $118.99 | $991,622.00 | 156% 5.34K to 13.68K | |
| 08-Oct-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 07-Oct-24 | Planned Option Sale | 7,794 | $355.54 | $2,771,080.00 | (57%) 13.68K to 5.88K | |
| 24-Sep-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 23-Sep-24 | Option Exercise | 8,334 | $118.99 | $991,622.00 | 195% 4.26K to 12.6K | |
| 24-Sep-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 23-Sep-24 | Planned Option Sale | 7,796 | $354.04 | $2,760,100.00 | (62%) 12.6K to 4.8K | |
| 23-Sep-24 4:30 PM View: | Mahon Paul A EVP & General Counsel | United Therapeutics Corp. (UTHR) | 19-Sep-24 | Disposition | 7,700 | $351.33 | $2,705,240.00 | (17%) 44.41K to 36.71K | |
| 23-Sep-24 4:30 PM View: | Mahon Paul A EVP & General Counsel | United Therapeutics Corp. (UTHR) | 19-Sep-24 | Option Exercise | 7,700 | $163.30 | $1,257,410.00 | 21% 36.71K to 44.41K | |
| 17-Sep-24 4:30 PM View: | Olian Judy D. Director | United Therapeutics Corp. (UTHR) | 17-Sep-24 | Option Exercise | 2,300 | $112.14 | $257,922.00 | 31% 7.41K to 9.71K | |
| 17-Sep-24 4:30 PM View: | Olian Judy D. Director | United Therapeutics Corp. (UTHR) | 17-Sep-24 | Option Exercise | 2,300 | $353.22 | $812,406.00 | (24%) 9.71K to 7.41K | |
| 17-Sep-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 16-Sep-24 | Planned Option Sale | 7,810 | $339.12 | $2,648,530.00 | (65%) 12.07K to 4.26K | |
| 17-Sep-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 16-Sep-24 | Option Exercise | 8,334 | $118.99 | $991,622.00 | 223% 3.74K to 12.07K | |
| 10-Sep-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 09-Sep-24 | Option Exercise | 8,332 | $118.99 | $991,381.00 | 260% 3.21K to 11.54K | |
| 10-Sep-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 09-Sep-24 | Planned Option Sale | 7,802 | $345.41 | $2,694,890.00 | (68%) 11.54K to 3.74K | |
| 05-Sep-24 4:30 PM View: | Patusky Christopher Director | United Therapeutics Corp. (UTHR) | 04-Sep-24 | Option Sale | 4,300 | $353.36 | $1,519,430.00 | (68%) 6.3K to 2.0K | |
| 05-Sep-24 4:30 PM View: | Patusky Christopher Director | United Therapeutics Corp. (UTHR) | 04-Sep-24 | Option Exercise | 4,300 | $175.43 | $754,349.00 | 215% 2.0K to 6.3K | |
| 05-Sep-24 4:30 PM View: | Patusky Christopher Director | United Therapeutics Corp. (UTHR) | 03-Sep-24 | Option Exercise | 700 | $175.43 | $122,801.00 | 35% 2.0K to 2.7K | |
| 05-Sep-24 4:30 PM View: | Patusky Christopher Director | United Therapeutics Corp. (UTHR) | 03-Sep-24 | Option Sale | 700 | $360.30 | $252,214.00 | (26%) 2.7K to 2.0K | |
| 26-Aug-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 26-Aug-24 | Option Sale | 1,133 | $347.60 | $393,831.00 | (11%) 10.41K to 9.28K | |
| 26-Aug-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 26-Aug-24 | Option Exercise | 6,666 | $118.99 | $793,153.00 | 178% 3.75K to 10.41K | |
| 26-Aug-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 26-Aug-24 | Planned Option Sale | 6,666 | $347.60 | $2,317,100.00 | (72%) 9.28K to 2.62K | |
| 28-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 26-Aug-24 | Option Exercise | 269 | $129.49 | $34,832.80 | < 1% 644.49K to 644.76K | |
| 28-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 26-Aug-24 | Planned Option Sale | 269 | $348.41 | $93,722.90 | (< 1%) 644.76K to 644.49K | |
| 26-Aug-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 26-Aug-24 | Option Exercise | 1,666 | $118.98 | $198,228.00 | 80% 2.08K to 3.75K | |
| 26-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 23-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K | |
| 26-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 23-Aug-24 | Planned Option Sale | 3,600 | $348.11 | $1,253,200.00 | (< 1%) 648.09K to 644.49K | |
| 26-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 22-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K | |
| 26-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 22-Aug-24 | Planned Option Sale | 3,600 | $346.82 | $1,248,570.00 | (< 1%) 648.09K to 644.49K | |
| 22-Aug-24 4:30 PM View: | Causey Christopher Director | United Therapeutics Corp. (UTHR) | 21-Aug-24 | Option Exercise | 1,210 | $132.30 | $160,083.00 | 29% 4.18K to 5.39K | |
| 22-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 21-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K | |
| 22-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 21-Aug-24 | Planned Option Sale | 3,600 | $350.14 | $1,260,500.00 | (< 1%) 648.09K to 644.49K | |
| 22-Aug-24 4:30 PM View: | Causey Christopher Director | United Therapeutics Corp. (UTHR) | 21-Aug-24 | Option Sale | 1,210 | $349.00 | $422,290.00 | (22%) 5.39K to 4.18K | |
| 22-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 20-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K | |
| 22-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 20-Aug-24 | Planned Option Sale | 3,600 | $346.03 | $1,245,700.00 | (< 1%) 648.09K to 644.49K | |
| 20-Aug-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 19-Aug-24 | Option Exercise | 1,666 | $118.98 | $198,228.00 | 106% 1.58K to 3.24K | |
| 20-Aug-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 19-Aug-24 | Option Sale | 1,162 | $329.02 | $382,321.00 | (12%) 9.91K to 8.75K | |
| 20-Aug-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 19-Aug-24 | Option Exercise | 6,666 | $118.99 | $793,153.00 | 205% 3.24K to 9.91K | |
| 20-Aug-24 4:30 PM View: | Edgemond James CFO and Treasurer | United Therapeutics Corp. (UTHR) | 19-Aug-24 | Planned Option Sale | 6,666 | $329.02 | $2,193,250.00 | (76%) 8.75K to 2.08K | |
| 21-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 19-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K | |
| 21-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 19-Aug-24 | Planned Option Sale | 3,600 | $344.18 | $1,239,050.00 | (< 1%) 648.09K to 644.49K | |
| 15-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 14-Aug-24 | Planned Option Sale | 3,600 | $324.50 | $1,168,200.00 | (< 1%) 648.09K to 644.49K | |
| 15-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 14-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K | |
| 15-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 13-Aug-24 | Planned Option Sale | 3,600 | $327.84 | $1,180,220.00 | (< 1%) 648.09K to 644.49K | |
| 15-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 13-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K | |
| 13-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 12-Aug-24 | Planned Option Sale | 3,600 | $334.14 | $1,202,910.00 | (< 1%) 648.09K to 644.49K | |
| 13-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 12-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K | |
| 13-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 09-Aug-24 | Planned Option Sale | 3,600 | $330.48 | $1,189,710.00 | (< 1%) 648.09K to 644.49K | |
| 13-Aug-24 4:30 PM View: | Rothblatt Martine A Chairperson & CEO Director | United Therapeutics Corp. (UTHR) | 09-Aug-24 | Option Exercise | 3,600 | $129.49 | $466,164.00 | < 1% 644.49K to 648.09K |
